#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Peripheral primitive neuroectodermal tumour of soft tissue Neuropathy peripheral Interstitial lung disease Pituitary-dependent Cushing's syndrome Duchenne muscular dystrophy Waldenstrom's macroglobulinaemia refractory Hyperphagia Frontotemporal dementia Chemical burn Extraskeletal ossification Astrocytoma malignant Nephropathy Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Hypertriglyceridaemia Pouchitis More trials…

    Learn about Rare Diseases

    Medulloblastoma Pleomorphic leiomyosarcoma – Diagnostics Congenital generalised lipodystrophy – Diagnostics IgA nephropathy – Life with Disease Mucopolysaccharidosis I – Life with Disease Metachromatic leukodystrophy – Trials in Disease Fragile X syndrome Splenic marginal zone lymphoma – Life with Disease Cholangitis sclerosing – Life with Disease Haemophilia A without inhibitors – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Anhydrous Cidofovir Omeprazole Specific Nucleic Acid Sna-Ebv Atropine Sulfate Oxitriptan Potassium Iodide Sotalol Lithium Carbonate Trazodone Insulin Icodec Alpelisib Vancomycin Carcik-Cd19 Cells GRNA-001 Eltrombopag Interleukin-1 [18F]Fapi-74 AZD4360 Busulfan Medroxyprogesterone Acetate More therapies…

    Learn about Your Condition

    Infant sedation Diabetic retinopathy Malignant glioma Erythema migrans Langerhans cell sarcoma Spinal muscular atrophy Hepatic encephalopathy Vulval cancer recurrent Nervous system disorder Biliary neoplasm External cephalic version Hyperparathyroidism secondary Uterine leiomyosarcoma Aplastic anaemia Generalised anxiety disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hopital Saint Antoine

Hopital Saint Antoine

184 Rue Du Faubourg Saint Antoine, Paris, 75571, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on EXL01 with Nivolumab and FOLFOX for First-Line Treatment in Patients with PD-L1 CPS ≥5 Metastatic Gastric Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • ANHYDROUS CALCIUM FOLINATE
    • Exl01
    • Fluorouracil Sodium
    France

  • Study on the Effects of Oseltamivir and Drug Combination for Patients with Pneumonia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Baloxavir Marboxil
    • Dexamethasone Ph. Eur.
    • Dexamethasone Sodium Phosphate
    Belgium Estonia France Italy The Netherlands Portugal +3

  • Study on the Effectiveness and Safety of Tinengotinib for Patients with Cholangiocarcinoma Resistant to Chemotherapy and FGFR Inhibitors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Irinotecan Hydrochloride
    Austria Belgium France Germany Italy Poland +2

  • Study of Dostarlimab for Patients with Untreated Locally Advanced Rectal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Dostarlimab
    France Germany Italy The Netherlands Spain

  • Study on the Effectiveness of Durvalumab and Bevacizumab for Patients with Liver Cancer at High Risk of Recurrence After Surgery or Ablation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Bevacizumab
    • Dextrose Bp
    • Durvalumab
    Austria France Germany Italy Poland

  • Study on Reducing HIV-HBV Treatment with Darunavir, Ritonavir, and Lamivudine for Patients with Controlled Co-Infection

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Darunavir
    • Dolutegravir Sodium
    • Lamivudine
    France

  • Study of Dostarlimab for Patients with Advanced or Metastatic Non-Colorectal/Non-Endometrial Cancer with dMMR/MSI, Compared to Standard Drug Combination

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Calcium Folinate
    • Capecitabine
    • Carboplatin
    France

  • Study on Managing Locally-Advanced Rectal Cancer with Oxaliplatin, Fluorouracil, and Irinotecan Hydrochloride for Patients Responding Well to Initial Chemotherapy

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Calcium Folinate
    • Capecitabine
    • Fluorouracil
    France

  • Study Comparing Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone with Ciltacabtagene Autoleucel or Stem Cell Transplant for Newly Diagnosed Multiple Myeloma Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bortezomib
    • Ciltacabtagene Autoleucel
    • Daratumumab
    Belgium Czechia France Germany Greece The Netherlands +3

  • Study on Capsaicin for Finger Pain in Digital Osteoarthritis Patients

    Recruiting

    3 1 1
    Investigated Drugs:
    • Capsaicin
    France
Previous Page
1 2 3 4 5 6 … 15
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!